Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
G Ndrepepa, A Kastrati - Journal of Clinical Medicine, 2023 - mdpi.com
Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …
The role and mechanisms of microvascular damage in the ischemic myocardium
BH Zhao, A Ruze, L Zhao, QL Li, J Tang… - Cellular and Molecular …, 2023 - Springer
Following myocardial ischemic injury, the most effective clinical intervention is timely
restoration of blood perfusion to ischemic but viable myocardium to reduce irreversible …
restoration of blood perfusion to ischemic but viable myocardium to reduce irreversible …
Assessment of coronary microcirculation alterations in a porcine model of no-reflow using ultrasound localization microscopy: a proof of concept study
O Demeulenaere, P Mateo, R Ferrera, PM Chiaroni… - …, 2023 - thelancet.com
Background Coronary microvascular obstruction also known as no-reflow phenomenon is a
major issue during myocardial infarction that bears important prognostic implications …
major issue during myocardial infarction that bears important prognostic implications …
The HbA1c/C-Peptide Ratio is Associated With the No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction
Currently, the gold standard treatment for ST-elevation myocardial infarction (STEMI) is
primary percutaneous coronary intervention (pPCI), but even after successful pPCI, a …
primary percutaneous coronary intervention (pPCI), but even after successful pPCI, a …
Pan-immune-inflammation value is independently correlated to impaired coronary flow after primary percutaneous coronary intervention in patients with St-segment …
F Şen, A Kurtul, Ö Bekler - The American Journal of Cardiology, 2024 - Elsevier
Immune-inflammatory biomarkers have been shown to be correlated with impaired coronary
flow (ICF) in ST-segment elevation myocardial infarction. In this study, we assessed the …
flow (ICF) in ST-segment elevation myocardial infarction. In this study, we assessed the …
Tongmai Yangxin pill alleviates myocardial no-reflow by activating GPER to regulate HIF-1α signaling and downstream potassium channels
T Chen, Y Zhang, M Chen, P Yang, Y Wang… - Pharmaceutical …, 2023 - Taylor & Francis
Abstract Context The Tongmai Yangxin pill (TMYX) has potential clinical effects on no-reflow
(NR); however, the effective substances and mechanisms remain unclear. Objective This …
(NR); however, the effective substances and mechanisms remain unclear. Objective This …
Lipidomic Predictors of Coronary No-Reflow
A Surendran, U Ismail, N Atefi, AK Bagchi, PK Singal… - Metabolites, 2023 - mdpi.com
The 'no-reflow'phenomenon (NRP) after primary percutaneous coronary intervention (PCI) is
a serious complication among acute ST-segment elevation myocardial infarction (STEMI) …
a serious complication among acute ST-segment elevation myocardial infarction (STEMI) …
A Novel Reperfusion Strategy for Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: A Prospective Case …
JF He, YX Yang, JY Li, L Liang, L Xu, Y Liu… - Journal of Clinical …, 2023 - mdpi.com
Background: Ischemia reperfusion injury (IRI) remains a major problem in patients with
acute ST-segment elevation myocardial infarction (STEMI) undergoing primary …
acute ST-segment elevation myocardial infarction (STEMI) undergoing primary …
[HTML][HTML] Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study
S Kozhukhov, A Parkhomenko, Y Lutay… - Hellenic Journal of …, 2024 - Elsevier
Objective Myocardial infarction (MI) is one of the leading causes of death in the world. Early
myocardial reperfusion improves acute MI survival. Bioflavonoid quercetin is known to have …
myocardial reperfusion improves acute MI survival. Bioflavonoid quercetin is known to have …
Predictive effect of triglyceride-glucose index on No-Reflow Phenomenon in patients with type 2 diabetes mellitus and acute myocardial infarction undergoing primary …
J Ma, M Wang, P Wu, X Ma, D Chen, S Jia… - Diabetology & Metabolic …, 2024 - Springer
Abstract Objective Triglyceride glucose (TyG) index is considered as a new alternative
marker of insulin resistance and a clinical predictor of type 2 diabetes mellitus (T2DM) …
marker of insulin resistance and a clinical predictor of type 2 diabetes mellitus (T2DM) …